144207-60-3

Basic information

• Product Name: (GLN18)-PF4 (15-22) (HUMAN)
• Synonyms: THR-THR-SER-GLN-VAL-ARG-PRO-ARG;(GLN18)-PF4 (15-22) (HUMAN);(GLN18)-PLATELET FACTOR 4 (15-22) (HUMAN);H-THR-THR-SER-GLN-VAL-ARG-PRO-ARG-OH;CT-112;CT-112 (HUMAN);(Gln18)-PF4 (15-22) (huMan), CT-112;CT1.26
• CAS NO: 144207-60-3
• Molecular Formula: C38H69N15O13
• Molecular Weight: 944.05
• Mol File: 144207-60-3.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.56±0.1 g/cm3(Predicted)
• Storage Temp.: -15°C
• PKA: 3.60±0.21(Predicted)
• CAS DataBase Reference: (GLN18)-PF4 (15-22) (HUMAN)(CAS DataBase Reference)
• NIST Chemistry Reference: (GLN18)-PF4 (15-22) (HUMAN)(144207-60-3)
• EPA Substance Registry System: (GLN18)-PF4 (15-22) (HUMAN)(144207-60-3)

Safety Data

• Hazardous Substances Data: 144207-60-3(Hazardous Substances Data)

Usage

General Description

(GLN18)-PF4 (15-22) (HUMAN) is a peptide fragment of the platelet factor 4 (PF4) protein, which is a member of the CXC chemokine family. PF4 is released from the alpha-granules of platelets and has various functions, including the regulation of blood clotting and inflammation. This specific peptide, (GLN18)-PF4 (15-22), is thought to have antiangiogenic properties, meaning it may inhibit the formation of new blood vessels. Additionally, it has been studied for its potential role in cancer and tumor growth, as well as its involvement in heparin-induced thrombocytopenia, a condition in which the body's immune system attacks platelets. Further research is needed to fully understand the biological function and potential therapeutic applications of this peptide.